84 related articles for article (PubMed ID: 11802382)
1. [Candidate gene approach for polyglutamine disease: isolation and characterization of human brain cDNAs containing CAG repeats].
Igarashi S; Amaya N; Tsuji S
Tanpakushitsu Kakusan Koso; 2001 Dec; 46(16 Suppl):2295-8. PubMed ID: 11802382
[No Abstract] [Full Text] [Related]
2. Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion disease.
Mackenzie IR; Butland SL; Devon RS; Dwosh E; Feldman H; Lindholm C; Neal SJ; Ouellette BF; Leavitt BR
BMC Neurol; 2006 Aug; 6():32. PubMed ID: 16945149
[TBL] [Abstract][Full Text] [Related]
3. [The advances in research on phosphorylation of polyglutamine disease].
Zhou YF; Jiang H; Tang JG; Tang BS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of polyglutamine-induced disease: A model for SCA1.
Klement IA; Zoghbi HY; Orr HT
Mol Genet Metab; 1999 Mar; 66(3):172-8. PubMed ID: 10066385
[TBL] [Abstract][Full Text] [Related]
5. A SCA7 CAG/CTG repeat expansion is stable in Drosophila melanogaster despite modulation of genomic context and gene dosage.
Jackson SM; Whitworth AJ; Greene JC; Libby RT; Baccam SL; Pallanck LJ; La Spada AR
Gene; 2005 Feb; 347(1):35-41. PubMed ID: 15715978
[TBL] [Abstract][Full Text] [Related]
6. A-overhang-dependent repeat expansion determination (ADRED).
Achmüller C; Köhler A; Bösch S; Schneider R
Biotechniques; 2008 Nov; 45(5):577-80. PubMed ID: 19007342
[TBL] [Abstract][Full Text] [Related]
7. Identification of CAG repeat-containing genes expressed in human brain as candidate genes for autosomal dominant spinocerebellar ataxias and other neurodegenerative diseases.
Tachikawa M; Nagai Y; Nakamura K; Kobayashi K; Fujiwara T; Han HJ; Nakabayashi Y; Ichikawa Y; Goto J; Kanazawa I; Nakamura Y; Toda T
J Hum Genet; 2002; 47(6):275-8. PubMed ID: 12111376
[TBL] [Abstract][Full Text] [Related]
8. [Molecular biology of polyglutamine diseases].
Owecki M; Kozubski W
Postepy Hig Med Dosw; 2002; 56(6):779-88. PubMed ID: 12661407
[TBL] [Abstract][Full Text] [Related]
9. Focal dystonia as a presenting sign of spinocerebellar ataxia 17.
Hagenah JM; Zühlke C; Hellenbroich Y; Heide W; Klein C
Mov Disord; 2004 Feb; 19(2):217-20. PubMed ID: 14978680
[TBL] [Abstract][Full Text] [Related]
10. [SCA17, a novel polyglutamine disease caused by the expansion of polyglutamine tracts in TATA-binding protein].
Nakamura K
Rinsho Shinkeigaku; 2001 Dec; 41(12):1123-5. PubMed ID: 12235815
[TBL] [Abstract][Full Text] [Related]
11. Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.
Pulst SM; Santos N; Wang D; Yang H; Huynh D; Velazquez L; Figueroa KP
Brain; 2005 Oct; 128(Pt 10):2297-303. PubMed ID: 16000334
[TBL] [Abstract][Full Text] [Related]
12. Spinocerebellar ataxia type 17 repeat in patients with Huntington's disease-like and ataxia.
Cellini E; Forleo P; Nacmias B; Tedde A; Bagnoli S; Piacentini S; Sorbi S
Ann Neurol; 2004 Jul; 56(1):163; author reply 163-4. PubMed ID: 15236416
[No Abstract] [Full Text] [Related]
13. Variation on a trinucleotide theme.
Yvert G; Mandel JL
Nat Med; 1999 Apr; 5(4):383-4. PubMed ID: 10202924
[No Abstract] [Full Text] [Related]
14. CAG repeat disorder models and human neuropathology: similarities and differences.
Yamada M; Sato T; Tsuji S; Takahashi H
Acta Neuropathol; 2008 Jan; 115(1):71-86. PubMed ID: 17786457
[TBL] [Abstract][Full Text] [Related]
15. The pathogenic agent in Drosophila models of 'polyglutamine' diseases.
McLeod CJ; O'Keefe LV; Richards RI
Hum Mol Genet; 2005 Apr; 14(8):1041-8. PubMed ID: 15757976
[TBL] [Abstract][Full Text] [Related]
16. Toward understanding polyglutamine-induced neurological disease in spinocerebellar ataxia type 1.
Orr HT; Zoghbi HY
Cold Spring Harb Symp Quant Biol; 1996; 61():649-57. PubMed ID: 9246491
[No Abstract] [Full Text] [Related]
17. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
[TBL] [Abstract][Full Text] [Related]
18. [Hereditary ataxias-overview].
Nishizawa M
Rinsho Shinkeigaku; 2001 Dec; 41(12):1114-6. PubMed ID: 12235812
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule ligand induces nucleotide flipping in (CAG)n trinucleotide repeats.
Nakatani K; Hagihara S; Goto Y; Kobori A; Hagihara M; Hayashi G; Kyo M; Nomura M; Mishima M; Kojima C
Nat Chem Biol; 2005 Jun; 1(1):39-43. PubMed ID: 16407992
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson's disease.
Taanman JW; Schapira AH
Neurosci Lett; 2005 Mar; 376(1):56-9. PubMed ID: 15694274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
